Evidence map›Paper›PMID 39333562›Full record

ArticleNature communications2024

Impact of six-month COVID-19 travel moratorium on Plasmodium falciparum prevalence on Bioko Island, Equatorial Guinea.

Dianna E B Hergott, Carlos A Guerra, Guillermo A García, Jeremías Nzamío Mba Eyono, Olivier T Donfack, Marcos Mbulito Iyanga, Restituto Mba Nguema Avue, Crisantos Nsue Abeso Nsegue, Teresa Ayingono Ondo Mifumu, Matilde Riloha Rivas and 5 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dianna E B HergottDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA. dhergott@uw.edu.ORCID 0000-0001-9417-4340
Carlos A GuerraMCD Global Health, Bioko Island Malaria Elimination Project, Silver Spring, Maryland, USA.ORCID 0000-0002-4069-9528
Guillermo A GarcíaMCD Global Health, Bioko Island Malaria Elimination Project, Silver Spring, Maryland, USA.ORCID 0000-0002-4430-4781
Jeremías Nzamío Mba EyonoMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.ORCID 0000-0002-2604-4234
Olivier T DonfackMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.
Marcos Mbulito IyangaMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.
Restituto Mba Nguema AvueMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.
Crisantos Nsue Abeso NsegueMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.
Teresa Ayingono Ondo MifumuMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.
Matilde Riloha RivasNational Malaria Control Program, Ministry of Health and Social Welfare, Malabo, Equatorial Guinea.
Wonder P PhiriMCD Global Health, Bioko Island Malaria Elimination Project, Malabo, Equatorial Guinea.
Sean C MurphyDepartment of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2048-0131
Brandon L GuthrieDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.
David L SmithInstitute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.ORCID 0000-0003-4367-3849
Jennifer E BalkusDepartment of Epidemiology, School of Public Health, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-9950-2523

Funding

Spatial Targeting and Adaptive Vector Control for Residual Transmission and Malaria Elimination in Urban African SettingsR01AI163398 · NIAID · UNIVERSITY OF WASHINGTON · PI SMITH, DAVID L. · 2021 to 2025
$3.2M
Bill and Melinda Gates Foundation (Bill & Melinda Gates Foundation) INV 030600NIAID NIH HHS R01 AI163398
6 · The paper itself

Abstract

Importation of malaria infections is a suspected driver of sustained malaria prevalence on areas of Bioko Island, Equatorial Guinea. Quantifying the impact of imported infections is difficult because of the dynamic nature of the disease and complexity of designing a randomized trial. We leverage a six-month travel moratorium in and out of Bioko Island during the initial COVID-19 pandemic response to evaluate the contribution of imported infections to malaria prevalence on Bioko Island. Using a difference in differences design and data from island wide household surveys conducted before (2019) and after (2020) the travel moratorium, we compare the change in prevalence between areas of low historical travel to those with high historical travel. Here, we report that in the absence of a travel moratorium, the prevalence of infection in high travel areas was expected to be 9% higher than observed, highlighting the importance of control measures that target imported infections.

Indexed as

COVID-19Malaria, FalciparumPlasmodium falciparumSARS-CoV-2TravelAdultEquatorial GuineaFemaleHumansIslandsMalePandemicsPrevalence

Identifiers

PMID39333562
PMCPMC11436818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.